OverviewChartNewsTraderScreen

UC AKT.ANL. 03/25 QIA/  DE000HD46PA5  /

gettex
05/06/2024  11:46:49 Chg.-0.180 Bid13:02:28 Ask13:02:28 Underlying Strike price Expiration date Option type
101.450EUR -0.18% 101.480
Bid Size: 125,000		 101.600
Ask Size: 125,000		 QIAGEN NV 36.00 - 28/03/2025 Call
GlobeNewswire 03/06 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 30/05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 30/05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 29/05 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 22/05 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 14/05 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 13/05 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 07/05 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 02/05 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 29/04 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire 25/04 deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire 24/04 QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire 18/04 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 09/04 QIAGEN N.V. to release results for Q1 2024 and hold webcast
GlobeNewswire 03/04 QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire 25/03 QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire 18/03 QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire 11/03 QIAGEN announces Form 20-F annual report filing for 2023 results
GlobeNewswire 27/02 QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire 27/02 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 15/02 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire 06/02 QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
TeleTrader 06/02 Europe higher at close, economic prints in spotlight